action over the cell cycle of CPT-ALA, CPT, or CPT+5-ALA, the cell
ratio was determined in each cycle phase by flow cytometry over the
C6 cell line. For this sake, cells were seeded in 12 well culture
plates and incubated with every molecule at 0.002, 0.4, and 1.6 μg
of CPTeq/mL) for 6 or 24 h at 37 °C under a humidified atmosphere
of 5% CO2. Afterward, C6 cells were fixed with 2% paraformaldehyde
and incubated 30 min at 37 °C with 2.5 mg/mL RNase A from bovine
pancreas (Sigma-Aldrich) and 2.5 mg/mL PI. Finally, C6 cells were
stored in ice and analyzed with FACSCanto system to determine population
cell percentage in each cycle phase. For every drug concentration
10 000 events were assessed with low flow. Cells with no staining
and treatment were used to delimitate C6 population, whereas cells
with no treatment were used as controls to define C6 normal distribution
in the cell cycle phases. Data were analyzed through BD FACSDiva software.
Four independent experiments were performed for every drug, and each
experiment was carried out in triplicate.